Article Date: Tuesday 21 10 08 15:00:00
Article Source: Crohn's News From Medical News Today
Main Article Link: http://www.medicalnewstoday.com/articles/126193.php
Data presented today at the United European Gastroenterology Week Congress (UEGW) show that a significantly greater proportion of patients with moderate to severe Crohn's disease experienced steroid-free remission and mucosal healing when receiving Remicade(R) (infliximab), either in combination with azathioprine or as monotherapy, compared to patients receiving azathioprine alone. |
Bookmark with: